The pharmaceutical industry from the US and Europe scored a major victory with the adoption, in 1994, of a binding agreement on intellectual property (Agreement on Trade Related Aspects of Intellectual Property Rights - TRIPS) in the context of the nascent World Trade Organization (WTO).
For years, it was the power chamber at the headquarters of the World Trade Organisation (WTO) in Geneva - the Director General’s Conference Room, more popularly known as the Green Room, where a handful of delegates would gather for important discussions and meetings.